Cancer immunotherapy: understanding personalised options
Cancer immunotherapy includes different medical strategies. Their suitability depends on tumour biology, previous treatments, immune status and the applicable regulatory framework.
What should be assessed?
Diagnosis and pathology, previous and current treatments, tumour biology, immune findings and the patient’s general condition must be considered together.
Evidence and limitations
Scientific evidence differs by tumour type and procedure. This portal provides information and does not replace medical advice or promise a treatment result.
Frequently asked questions
Is this information a treatment recommendation?
No. Individual decisions require qualified medical assessment.
Can the approach be combined with standard treatment?
Possible combinations and timing must be assessed by the treating oncological team.
